Allarity Therapeutics Inc
NASDAQ:ALLR
Cash Flow Statement
Cash Flow Statement
Allarity Therapeutics Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
(27)
|
(30)
|
(35)
|
(30)
|
(16)
|
(16)
|
(14)
|
(13)
|
(12)
|
(12)
|
(12)
|
(19)
|
(25)
|
(23)
|
(24)
|
(15)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Deffered Taxes |
0
|
(1)
|
(1)
|
(1)
|
(2)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Stock-Based Compensation |
6
|
7
|
7
|
7
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
6
|
7
|
7
|
7
|
1
|
(0)
|
(2)
|
(2)
|
(4)
|
(4)
|
(5)
|
4
|
8
|
8
|
11
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
6
|
3
|
4
|
5
|
(0)
|
3
|
3
|
1
|
3
|
6
|
1
|
(1)
|
0
|
(3)
|
(3)
|
(0)
|
|
| Cash from Operating Activities |
(15)
N/A
|
(21)
-39%
|
(25)
-20%
|
(19)
+25%
|
(17)
+10%
|
(14)
+15%
|
(13)
+12%
|
(14)
-8%
|
(13)
+6%
|
(11)
+13%
|
(16)
-43%
|
(16)
0%
|
(17)
-10%
|
(19)
-7%
|
(17)
+9%
|
(15)
+12%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Other Items |
1
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
1
N/A
|
2
+80%
|
2
N/A
|
1
-55%
|
1
-3%
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
35
|
0
|
33
|
19
|
(2)
|
(0)
|
6
|
13
|
14
|
13
|
35
|
33
|
37
|
48
|
18
|
15
|
|
| Net Issuance of Debt |
1
|
1
|
1
|
(0)
|
1
|
0
|
(1)
|
(2)
|
(3)
|
(1)
|
(0)
|
(0)
|
0
|
(1)
|
0
|
0
|
|
| Other |
(2)
|
0
|
(3)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
34
N/A
|
34
N/A
|
32
-7%
|
16
-49%
|
(1)
N/A
|
(0)
+88%
|
5
N/A
|
11
+128%
|
11
-4%
|
11
+2%
|
35
+209%
|
33
-5%
|
37
+11%
|
47
+27%
|
18
-62%
|
15
-14%
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
(1)
|
(1)
|
(1)
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(2)
|
(2)
|
|
| Net Change in Cash |
19
N/A
|
14
-26%
|
7
-48%
|
(2)
N/A
|
(18)
-970%
|
(14)
+19%
|
(7)
+49%
|
(3)
+65%
|
(2)
+27%
|
0
N/A
|
19
+110 565%
|
17
-9%
|
19
+13%
|
27
+41%
|
(1)
N/A
|
(2)
-9%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(15)
N/A
|
(21)
-39%
|
(25)
-20%
|
(19)
+25%
|
(17)
+10%
|
(14)
+15%
|
(13)
+12%
|
(14)
-8%
|
(13)
+6%
|
(11)
+13%
|
(16)
-43%
|
(16)
0%
|
(18)
-12%
|
(19)
-5%
|
(17)
+9%
|
(15)
+12%
|
|